Director/PDMR Shareholding

Summary by AI BETAClose X

Breedon Group plc announced that Clive Watson, a Non-executive Director and PDMR, made an initial notification of transactions involving the purchase of ordinary shares. On May 11, 2026, Watson acquired a total of 16,477 ordinary shares across three transactions at prices ranging from £3.00489 to £3.008 per share, with an aggregate cost of £49,547.80.

Disclaimer*

Breedon Group PLC
13 May 2026
 

 

 

 


LEI: 213800DQGNQE3X76WS92

 

13 May 2026

BREEDON GROUP plc

(Breedon or the Company)

 

Notification and public disclosure of transactions by persons discharging managerial

responsibilities (PDMRs) and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Watson

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.007 per share

2,529

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

2,529

 

£7,604.70

e)

Date of transaction

2026-05-11

f)

Place of the transaction

XTX Mids, XTXM

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.00489 per share

2,677

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

2,677

 

£8,044.10

e)

Date of transaction

2026-05-11

f)

Place of the transaction

JP Morgan Systematic Internaliser, JPSI

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.008 per share

11,271

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

11,271

 

£33,903.17

e)

Date of transaction

2026-05-11

f)

Place of the transaction

Optiver Systematic Internaliser, OPSI

 

 

 

 

Enquiries:

 

Breedon Group plc                                                        www.breedongroup.com  

James Atherton-Ham, Company Secretary                       +44 (0)1332 694000

Anthony Thorpe, Director of Corporate Development

& Investor Relations                                                        +44 (0) 7935 503649

 

MHP (Public Relations Adviser)                                    +44 (0) 7508 012457

Reg Hoare, Rachel Farrington, Charles Hirst                    breedon@mhpgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings